Breast Cancer
What's New
Last Posted: Apr 18, 2024
- Uptake of screening and risk-reducing recommendations among women with hereditary breast and ovarian cancer syndrome due to pathogenic BRCA1/2 variants evaluated at a large urban comprehensive cancer center.
Hadeel Assad et al. Breast Cancer Res Treat 2024 - A Semiautonomous Deep Learning System to Reduce False-Positive Findings in Screening Mammography.
Stefano Pedemonte et al. Radiol Artif Intell 2024 e230033 - Factors Influencing Adherence to the Risk Management Program for Women With a Genetic Predisposition to Breast Cancer: Real-World Data from a French Multicenter Program.
Ke Zhou et al. Oncologist 2024 - Population-based BRCA germline mutation screening in the Han Chinese identifies individuals at risk of BRCA mutation-related cancer: experience from a clinical diagnostic center from greater Shanghai area.
Zhiyuan Wu et al. BMC Cancer 2024 24(1) 411 - Application of deep learning on mammographies to discriminate between low and high-risk DCIS for patient participation in active surveillance trials.
Sena Alaeikhanehshir et al. Cancer Imaging 2024 24(1) 48 - Socioecologic Factors and Racial Differences in Breast Cancer Multigene Prognostic Scores in US Women.
Ashwini Z Parab et al. JAMA Netw Open 2024 4 (4) e244862 - A scoping review of web-based, interactive, personalized decision-making tools available to support breast cancer treatment and survivorship care.
Kaitlyn M Wojcik et al. J Cancer Surviv 2024 - Prediction and Diagnosis of Breast Cancer Using Machine and Modern Deep Learning Models.
Seeta Devi et al. Asian Pac J Cancer Prev 2024 25(3) 1077-1085 - Is Oncotype DX testing informative for breast cancers with low ER expression? A retrospective review from a biomarker testing referral center.
John Loggie et al. Breast 2024 75103715 - A Scoping Review of Personalized, Interactive, Web-Based Clinical Decision Tools Available for Breast Cancer Prevention and Screening in the United States.
Dalya Kamil et al. MDM Policy Pract 2024 9(1) 23814683241236511
More
About Cancer PHGKB
Cancer PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other materials that address the translation of genomic and other precision health discoveries into improved health care and prevention related to cancer...more
Content Summary
- CDC Information (21)
- NIH Information (17)
- COVID-19 (54)
- CDC Genomics and Precision Health Publications (42)
- Human Genome Epidemiologic Studies (10008)
- GWAS Studies (131)
- Tier-Classified Guidelines (48)
- Genomics Precision Health (3438)
- Non-Genomics Precision Health (392)
- Pathogen Advanced Molecular Detection (3)
Common Type
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 18, 2024
- Content source: